France· FR:61068069
ZINNAT 125 mg/5 ml ENFANTS ET NOURRISSONS, granulés pour suspension buvable en flacon
A medicinal product containing céfuroxime axétil, registered in France by SANDOZ, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉFUROXIME AXÉTIL
- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 4
4 priced- cip1334009334032871 flacon en verre jaune(brun) de 40 ml de suspension buvable reconstituée avec seringue doseuse pour administration orale de 5 mlEUR 5.03
- cip1334009334033481 flacon en verre jaune(brun) de 50 ml de suspension buvable reconstituée avec seringue doseuse pour administration orale de 5 mlEUR 5.03
- cip1334009334035771 flacon en verre jaune(brun) de 80 ml de suspension buvable reconstituée avec seringue doseuse pour administration orale de 5 mlEUR 8.99
- cip1334009334036381 flacon en verre jaune(brun) de 100 ml de suspension buvable reconstituée avec seringue doseuse pour administration orale de 5 mlEUR 8.99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Céfuroxime axétil in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMEDOXINMedochemie Ltd., Limassol
- United StatesCefuroxime axetilAscend Laboratories, LLC
- BelgiumCefuroxim Krka 250 mgKRKA d.d. Novo mesto
- FinlandCefuroxime AurobindoAurobindo Pharma Ltd
- GermanyCefuraxAristo Pharma Gmbh (Art 57)
- IrelandZinnat 125 mg/5 ml granules for oral suspensionSandoz Pharmaceuticals d.d.
- NorwayCefuroxim 1a pharma1 A Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Cefuroxim 1a Pharma, Cefuroxim Sandoz
- Belgium · Cefuroxime Eg, Zinnat
- Bulgaria · Cefurocon, Зинат
- Cyprus · Zinnat
- Czechia · Xorimax, Zinnat
- Germany · Cefurax, Cefuroxim 1 A Pharma
- Denmark · Cefudoc
- Estonia · Zinnat
- Spain · Cefuroxima Aurovitas, Cefuroxima Pensa
- United Kingdom (Northern Ireland) · Cefuroxime Sandoz, Zinnat
- Greece · Cupax, Medoxem
- Croatia · Xorimax, Zinnat
- Hungary · Zinnat
- Ireland · Cefuroxime Aurobindo, Zinnat
- Iceland · Kefzero
- Italy · Cefuroxima Mylan, Cefuroxima Sandoz
- Lithuania · Cefuroxime Ingen Pharma, Zinnat
- Luxembourg · Cefuroxime Eg, Zinnat
- Malta · Cefuroxime Puren, Zinnat
- Netherlands · Cefuroximaxetil Sandoz B.V.
- Poland · Bioracef, Cefuroxime Axetil Aurovitas
- Portugal · Cefuroxima Aurobindo, Cefuroxima Ccav
- Romania · Cefuroximă Arena, Cefuroxima Atb
- Slovenia · Zinnat
- Slovakia · Zinnat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e63e8a3b-d894-470c-b251-540712369a8d GET /v1/drugs/e63e8a3b-d894-470c-b251-540712369a8d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61068069",
"date_amm": "1991-08-08",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "CÉFUROXIME AXÉTIL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "granulés pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about céfuroxime axétil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.